CD8A and neoplasm: LAG3 and PD-1 co-expression has been used to identify dysfunctional CD8+ T cells in human tumors with their co-blockade in ovarian cancer improving proliferation and cytokine production by tumor-Ag-specific CD8+ T cells [63].